IVF

MKT CAP:$3M

INVO Fertility, Inc.

Market Cap

$3M

Healthcare·Medical - Devices·🇺🇸 United States·NASDAQ

Healthcare·Medical - Devices·🇺🇸·NASDAQ

Stock Price

$2.17+$1.27 (+141.67%)

Apr 21, 2026

Company Details

INVO Fertility, Inc. operates as a revenue-generating fertility business. It also focuses on the development of class clinical-stage assets in oncology and autoimmune diseases. The company was founded on January 5, 2007 and is headquartered...

CEO

Steven Shum

IPO Date

Nov 2, 2020

Website

www.invobioscience.com

Key Metrics TTM

Revenue

$5M

+24.4% YoY

Net Income

-$6M

EPS (Diluted)

-$6.96

Free Cash Flow

-$8M

Revenue / Share

$16.57

Gross Margin

38.4%

Operating Margin

-86.5%

Net Margin

-120.6%

FCF Margin

-144.8%

P/S

0.6x

P/E

—

Earnings Reports

Q4 2024

May 6, 2026

PENDING

Q3 2024

Sep 30, 2024

$1M+47.0%EPS -$5.04

Q1 2024

Mar 31, 2024

$2MEPS -$0.42

Q4 2023

Dec 31, 2023

$1MEPS -$0.80

Q3 2023

Sep 30, 2023

$974.9KEPS -$0.70

Revenue & Profitability

Quarter	Revenue	Gross Profit	Operating Income
Q1 18	$104.1K	$89.7K	-$140.3K
Q3 18	$125.0K	$109.7K	-$189.9K
Q4 18	$155.0K	$111.1K	-$513.4K
Q1 19	$189.4K	$178.5K	-$349.1K
Q2 19	$658.6K	$603.4K	-$65.8K
Q3 19	$303.6K	$258.6K	-$632.4K
Q4 19	$328.6K	$300.1K	-$740.8K
Q1 20	$258.6K	$228.6K	-$1M
Q2 20	$246.1K	$224.9K	-$1M
Q3 20	$336.1K	$308.7K	-$1M
Q1 21	$684.5K	$621.8K	-$2M
Q4 21	$3M	$3M	$503.6K
Q3 23	$974.9K	$393.9K	-$886.3K
Q4 23	$1M	$495.0K	-$2M
Q1 24	$2M	$726.1K	-$946.4K
Q3 24	$1M	$444.7K	-$1M

Valuation

Quarter	P/S	P/E
Q1 18	8.9x	—
Q3 18	7.8x	—
Q4 18	6.4x	—
Q1 19	5.2x	—
Q2 19	2.6x	—
Q3 19	2.3x	—
Q4 19	2.0x	—
Q1 20	1.9x	—
Q2 20	2.6x	—
Q3 20	2.5x	—
Q1 21	1.9x	—
Q4 21	0.7x	—
Q3 23	0.6x	—
Q4 23	0.5x	—
Q1 24	0.4x	—
Q3 24	0.6x	—

Operating Cash Flow

Quarter	Operating CF	Free CF
Q4 21	-$2M	-$1M
Q1 22	-$2M	-$2M
Q2 22	-$2M	-$2M
Q3 22	-$2M	-$2M
Q4 22	-$1M	-$1M
Q1 23	-$1M	-$1M
Q2 23	-$2M	-$2M
Q3 23	-$1M	-$1M
Q4 23	-$714.9K	-$789.9K
Q1 24	-$260.6K	-$310.3K
Q2 24	-$1M	-$2M
Q3 24	-$640.8K	-$640.8K
Q4 24	-$617.4K	-$696.3K
Q1 25	-$4M	-$4M
Q2 25	-$2M	-$2M
Q3 25	-$2M	-$2M

Capital Expenditures

Quarter	CapEx
Q4 21	$328.5K
Q1 22	$5.7K
Q2 22	$2.7K
Q3 22	$2.6K
Q4 22	$135
Q1 23	$0
Q2 23	$261.5K
Q3 23	$108.2K
Q4 23	$75.0K
Q1 24	$49.7K
Q2 24	$55.1K
Q3 24	$0
Q4 24	$78.9K
Q1 25	$14.7K
Q2 25	$8.9K
Q3 25	$8.1K

CapEx

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q1 18	+99.3%	+11.6%
Q3 18	+55.7%	+48.0%
Q4 18	+127.2%	+214.5%
Q1 19	+132.8%	+93.5%
Q2 19	+532.5%	+196.4%
Q3 19	+142.8%	+197.2%
Q4 19	+112.0%	+60.0%
Q1 20	+36.5%	+207.3%
Q2 20	-62.6%	+80.7%
Q3 20	+10.7%	+71.4%
Q1 21	+108.3%	+109.9%
Q4 21	+1078.9%	+53.7%
Q3 23	+296.2%	+42.2%
Q4 23	+311.1%	+80.2%
Q1 24	+130.3%	+12.4%
Q3 24	-53.0%	+7.4%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q4 21	$0	0.0%
Q1 22	$738.7K	—
Q2 22	$567.9K	—
Q3 22	$0	—
Q4 22	$412.2K	—
Q1 23	$522.2K	—
Q2 23	$0	—
Q3 23	$265.5K	27.2%
Q4 23	$179.5K	13.0%
Q1 24	$213.8K	13.6%
Q2 24	$1M	—
Q3 24	$106.3K	7.4%
Q4 24	$169.4K	—
Q1 25	$70.7K	—
Q2 25	$680.7K	—
Q3 25	$0	—

OpEx Breakdown

Quarter	R&D	SG&A
Q1 18	—	$230.0K
Q3 18	—	$299.5K
Q4 18	—	$624.6K
Q1 19	—	$527.6K
Q2 19	—	$669.2K
Q3 19	—	$891.0K
Q4 19	—	$1M
Q1 20	$30.1K	$2M
Q2 20	$34.9K	$1M
Q3 20	$112.6K	$1M
Q1 21	$66.3K	$2M
Q4 21	$63.8K	$2M
Q3 23	$2.7K	$1M
Q4 23	$5.9K	$2M
Q1 24	$4.9K	$1M
Q3 24	—	$2M

War Chest

Quarter	Cash	Short-term Investments	Total
Q1 18	$35.4K	$0	$35.4K
Q2 18	$720.3K	$0	$720.3K
Q3 18	$548.0K	$0	$548.0K
Q4 18	$212.2K	$0	$212.2K
Q1 19	$3M	$0	$3M
Q2 19	$3M	$0	$3M
Q3 19	$2M	$0	$2M
Q4 19	$1M	$0	$1M
Q1 20	$350.0K	$0	$350.0K
Q2 20	$2M	$0	$2M
Q3 20	$908.3K	$0	$908.3K
Q2 22	$2M	$0	$2M
Q3 22	$285.7K	$0	$285.7K
Q4 22	$90.1K	$0	$90.1K
Q1 23	$2M	$0	$2M
Q2 23	$112.5K	$0	$112.5K

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change	YoY Change
Q1 18	896K	+1.1%	+1.8%
Q3 18	922K	+2.9%	+4.4%
Q4 18	946K	+2.6%	+7.0%
Q1 19	963K	+1.9%	+8.7%
Q2 19	970K	+0.8%	+8.3%
Q3 19	972K	+0.2%	+5.5%
Q4 19	977K	+0.5%	+3.3%
Q1 20	984K	+0.7%	+2.1%
Q2 20	987K	+0.3%	+1.7%
Q3 20	618K	-37.3%	-36.4%
Q1 21	2M	+219.9%	+102.4%
Q4 21	2M	+20.6%	+142.6%
Q3 23	4M	+49.0%	+260.2%
Q4 23	2M	-29.9%	+303.1%
Q1 24	4M	+52.5%	+92.2%
Q3 24	324K	-91.5%	-86.4%

Shares Outstanding